Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Preliminary results of TRAP study-MedSci.cn

Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Preliminary results of TRAP study

Zhang, J; Dong, Q; Wang, Y; Diao, Y; Cui, X; Man, L; Zhang, J; Zhang, Y; Wu, T; Dong, Y; Zhang, J; Huang, Y; Wang, S

ANNALS OF ONCOLOGY, 2022; 33 (7): S730

科室
- - 订阅+
  - 更多科室
工具
服务